Infectious diseases clinical pharmacists play a critical role in developing and updating the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Two ACCP members were recently selected to join the Pharmacology Team of the Guidelines Panel on the basis of their expertise in drug therapy in the management of HIV-associated opportunistic infections (OIs):

• Daniel Chastain, Pharm.D., BCIDP, University of Georgia College of Pharmacy
• Katherine Yang, Pharm.D., MPH, University of California, San Francisco, School of Pharmacy

Chastain and Yang will join seven other clinical pharmacists on the panel’s Pharmacology Team led by Safia Kuriakose, Pharm.D., of the Frederick National Laboratory for Cancer Research (in support of NIAID, NIH). The Pharmacology Team works with subject group leaders across the guidelines to review chapter content, create and update the summary tables for each OI chapter, and maintain the tables for the prevention and treatment of OIs, drug-drug interactions, adverse drug reactions, and renal dosing recommendations.

The Guidelines Panel is a working group of the Office of AIDS Research Advisory Council of the NIH and works in collaboration with the CDC and Infectious Diseases Society of America/HIV Medicine Association. The guidelines serve as a living document, and each chapter is updated as new evidence emerges that warrants changes in recommendations.